Showing results (251-260 of 592) with videos related to

Sort By:
Pageof 60
Oncology|February 28, 2009
Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancersMaria S Pino, Michele Milella, Alain Gelibter, et al.
Igiene E Sanita Pubblica|June 12, 2019
[Use of the Lean methodology in the management of cancer patients in a University Hospital, Italy: First results]Antonio Giulio De Belvis, Carmen Angioletti, Serena Traglia, et al.
Geriatrics (Basel, Switzerland)|October 26, 2022
Safety and Efficacy of a First-Line Chemotherapy Tailored by G8 Score in Elderly Metastatic or Locally Advanced Gastric and Gastro-Esophageal Cancer Patients: A Real-World AnalysisIna Valeria Zurlo, Carmelo Pozzo, Antonia Strippoli, et al.
Anti-Cancer Drugs|March 8, 2006
Weekly paclitaxel, 5-fluorouracil and folinic acid with granulocyte colony-stimulating factor support in metastatic breast cancer patients: a phase II studyCecilia Nistico, Emilio Bria, Biagio Agostara, et al.
Frontiers in Oncology|March 27, 2023
Case report: Vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional responseMariangela Pasqualoni, Armando Orlandi, Antonella Palazzo, et al.
Expert Review of Anticancer Therapy|June 21, 2022
Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areasLorenzo Belluomini, Alice Avancini, Luca Pasqualin, et al.
Interactive Cardiovascular and Thoracic Surgery|August 5, 2020
Prognostic score for survival with pulmonary carcinoids: the importance of associating clinical with pathological characteristicsMarco Chiappetta, Isabella Sperduti, Leonardo Petracca Ciavarella, et al.
Breast (Edinburgh, Scotland)|October 27, 2017
External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experienceGaia Griguolo, William Jacot, Eva Kantelhardt, et al.
Annals of Surgical Oncology|February 9, 2011
Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancerValentina Guarneri, Annarita Pecchi, Federico Piacentini, et al.
Clinical Breast Cancer|October 28, 2008
Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278)Valentina Guarneri, Antonio Frassoldati, Paolo Bruzzi, et al.
Pageof 60